FUJIFILM CELLULAR DYNAMICS INC.

In News

Interview With Kaz Hirao, President & COO at Fujifilm Cellular Dynamics - BioInformant

BioInformant - Sep 19, 2025

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics - Business Wire

Business Wire - Nov 18, 2025

Fujifilm Cellular Dynamics Names Delara Motlagh as COO - Contract Pharma

Contract Pharma - Apr 29, 2025

The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant

BioInformant - Mar 05, 2026

Kenai Advances Allogeneic Stem Cell Therapy for Parkinson’s - San Diego Business Journal

San Diego Business Journal - Dec 17, 2025

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases - PR Newswire

PR Newswire - May 17, 2021

Fujifilm Cellular Dynamics Launches Human iPSC-Derived iCell Sensory Neurons - Contract Pharma

Contract Pharma - Sep 10, 2024

FUJIFILM Cellular Dynamics to Establish New Facility for Production of Human iPS Cell Therapy Applications - PR Newswire

PR Newswire - Jan 03, 2019

Dominance of Cellular Dynamics International (CDI) within iPSC Marketplace - BioInformant

BioInformant - Oct 01, 2024

Century Therapeutics, FUJIFILM Cellular Dynamics Expand Cell Therapy Pact - Contract Pharma

Contract Pharma - Nov 09, 2023

Century Therapeutics and FUJIFILM Cellular Dynamics to Commercialize iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases - BioInformant

BioInformant - Dec 22, 2023

Promega and Fujifilm Cellular Dynamics Enter Assay Development Partnership - Contract Pharma

Contract Pharma - Mar 10, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment